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OBJECTIVE — This research investigated recent changes in the prevalence and management
status of diabetes among Korean adults.
RESEARCH DESIGN AND METHODS — The Korea National Health and Nutrition
Examination Survey (KNHANES), a nationwide survey examining the general health and nutri-
tion status of the Korean people, was conducted in 1998, 2001, and 2005. Using the ﬁrst (1998;
n  5,645), second (2001; n  4,154), and third (2005; n  4,628) KNHANES datasets, in the
present study, we estimated the prevalence of diabetes among Korean adults (aged 30 years),
the proportions of known cases of diabetes, and the proportions of well-controlled cases of
diabetes,asdeﬁnedbyeithertheAmericanDiabetesAssociation(A1C7%)ortheInternational
Diabetes Federation guidelines (A1C 6.5%).
RESULTS — In 2005, the prevalence of diabetes was estimated to be 9.1% (2.58 million
people:10.2%ofmenand7.9%ofwomen),including6.2%withknowndiabetesand2.9%with
newlydiagnoseddiabetes.Theprevalenceofimpairedfastingglucosewas17.4%(4.94million
people). The proportion of known cases of diabetes drastically increased from 23.2% in 1998 to
41.2% in 2001 and 68.0% in 2005 (P  0.0001). Among known diabetic patients in 2005, 43.5
and 22.9% had A1C levels 7.0 and 6.5%, respectively.
CONCLUSIONS — The overall prevalence of diabetes in Korea has not changed signiﬁ-
cantly between 1998 and 2005. Physician diagnosis and treatment rates of diabetes have signif-
icantly improved during this period, but glycemic control was still poorer than that in other
developed countries.
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D
iabetes has emerged as an impor-
tant social issue worldwide, partic-
ularly in some Asian countries
(1–4). The increased prevalence is prob-
ablyattributabletorapideconomicdevel-
opment, improved living standards, an
aging population, and a Westernized life-
style(3,4).InKorea,diabetesanditscom-
plications have become a major cause of
morbidity and mortality. For example,
themortalityrateduetodiabeteshasdou-
bled during the last decade, increasing
from17.2per100,000personsin1995to
24.5 per 100,000 persons in 2005 (5).
The prevalence of diabetes also increased
rapidly in Korea. Estimated at 1% in
1970 (6) and 7.2% in the early 1990s
(7), the prevalence rose to 7.6% of the
adult population according to an analy-
sis of the 2001 Korea National Health
and Nutrition Examination Survey
(KNHANES) (8). Considering the impact
of suboptimal diabetes control on public
health,themanagementstatusofdiabetes
is as relevant as its prevalence. Rapid eco-
nomic growth over the past 3 decades has
brought many changes in Korea, such as
better education, frequent oversea travels
and international exchange, and the
world’s fastest Internet connections, en-
abling easy access to information nation-
wide and worldwide (9). These changes
made Koreans more interested in a
healthy life and forced the government to
pay more attention to the issues of health
and social welfare. The increasing atten-
tion to health and welfare is expected to
improve management and control of dia-
betes in Korea. However, recent changes
inthemanagementstatusofdiabeteshave
not been adequately studied at the na-
tional level. Thus, we investigated recent
changes in the prevalence, diagnosis,
treatment, and control rates of diabetes
among Korean adults based on the 1998,
2001, and 2005 KNHANES data.
RESEARCH DESIGN AND
METHODS— The Ministry of Health
and Welfare of Korea conducted a series
of three KNHANES in 1998, 2001, and
2005 to examine the general health
and nutrition status of Koreans (8). The
KNHANES consists of four different surveys:
a health interview survey, a health behav-
ior survey, a health examination survey,
andanutritionsurvey.Inthethird(2005)
KNHANES, 10,816 individuals aged 1
year (including 6,657 aged 30 years)
weresampledassubjectsofthehealthex-
amination survey. Among them, 7,597
individuals (including 4,818 aged 30
years) participated in the examination:
the response rate was 70.2% for age 1
year and 72.4% for age 30 years. In the
presentstudy,weanalyzed4,628subjects
aged 30 years (1,977 men and 2,651
women), after exclusion of 190 people
withoutappropriatefastingbloodtests.In
addition, 4,154 subjects (75.9%; 1,802
men and 2,352 women) from the 2001
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2016 DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 care.diabetesjournals.orgKNHANES and 5,645 subjects (87.3%;
2,525 men and 3,120 women) from the
1998 KNHANES were analyzed for com-
parison between the survey years.
The subjects were instructed to ﬁnish
meals before 7:00 P.M. on the day before
blood sampling and to drink only bottled
water after 7:00 P.M. The next morning,
blood (2 ml) was collected into a NaF
container. On the same day, the samples
were properly processed, immediately re-
frigerated,andtransportedincoldstorage
to the Central Testing Institute in Seoul,
Korea.Plasmaglucosewasmeasuredwith
the hexokinase method (ADVIA 1650
system, Bayer HealthCare, Tarrytown,
NY)in2005.Forsubjectswithahistoryof
diabetes or whose fasting plasma glucose
(FPG) met the criteria for diabetes in the
examination, A1C was measured using a
Variant II high-performance liquid chro-
matography assay (Bio-Rad, Carlsbad,
CA). Conversely blood was taken into a
plain tube, and serum glucose was mea-
sured with the glucose oxidase/peroxidase
method(Hitachi747autoanalyzer;Hitachi,
Tokyo, Japan) in 1998 and 2001.
In 2005, the subjects were asked to
conﬁrm fasting for 8 h. Those who had
not fasted for 8 h were scheduled to re-
turn for another examination. If no time
was available, the food that had been
eaten was recorded and the study contin-
ued; however, data from these subjects
were not included in the analysis. How-
ever, in 1998 and 2001, no subjects were
excluded before sampling because they
were asked about fasting after the sam-
pling. As a result, participants who had
fasted for 8 h comprised 9.9, 21.8, and
2.5% of the total sample in the 1998,
2001, and 2005 surveys, respectively.
The diagnostic criteria for diabetes
were obtained from the 1997 and 2003
revisions of the American Diabetes Asso-
ciation guidelines (10,11). Diabetes was
diagnosed in subjects with an FPG 126
mg/dl;impairedfastingglucose(IFG)was
deﬁned by FPG between 100 and 125
mg/dl. Those who were identiﬁed in the
health interview survey as having had a
previous diagnosis of diabetes by a health
care professional were classiﬁed as
“known cases of diabetes.” Those who
were ﬁrst diagnosed with diabetes in this
study were classiﬁed as “newly diagnosed
cases of diabetes.” The number of people
with diabetes was the sum of those with
known cases of diabetes and those with
newly diagnosed cases of diabetes. The
proportionwithadequateglucosecontrol
was deﬁned as the number of patients
with an A1C of 6.5 or 7.0% among
those with known cases of diabetes. A1C
7.0% is the standard adopted by the
American Diabetes Association (12),
whereas A1C 6.5% is suggested by the
International Diabetes Federation (13).
All sampling and weight variables
were stratiﬁed, and the SAS survey proce-
dure was used for the statistical analysis.
For prevalence calculations, we used the
stratiﬁcation variables and sampling
weightsdesignatedbytheKoreanCenters
for Disease Control and Prevention,
whichwerebasedonthesampledesignof
each survey year. The sampling weights
were adjusted for nonresponse according
to demographic factors after surveys were
completed. The SAS SurveyFreq proce-
durewasperformedwithclusterasasam-
pling-district variable, and prevalence
was reported with 95% CI. The numbers
of cases of diabetes and IFG were calcu-
latedbyapplyingthesex-andage-speciﬁc
prevalence to the 2005 Korean popula-
tionestimateforeachsexandagestratum.
The total number of adults aged 30
years was considered to be 28,283,845
(13,853,415 men and 14,430,430
women) in 2005. The SAS SurveyReg
procedure was used to compare differ-
encesbetweensexesandsurveyyears.For
the purpose of comparison, prevalence,
diagnosis, and treatment rates in 1998
and 2001 were also adjusted to the age
structure of the 2005 Korean population.
The reported P values were two-tailed,
and P  0.05 was considered to be
signiﬁcant.
RESULTS— In 2005, the prevalence
of diabetes in adults aged 30 years was
9.1% in the population (estimated to be
2.58 million people), including 10.2% of
men and 7.9% of women (Table 1). The
prevalence of individuals with known
cases of diabetes was 6.2% and that of
individuals with newly diagnosed diabe-
tes was 2.9%. In 2005, the prevalence of
IFGwas17.4%(estimatedtobe4.94mil-
lionpeople)ofadultsaged30years.Di-
abetes and IFG increased dramatically
with age. Among patients aged 60
years, the prevalence of diabetes was esti-
mated to be 20%, and the prevalence of
IFG was about 26%. Diabetes and IFG
were more frequent in men than in
women.
The age-standardized prevalence of
diabetes among those aged 30 years de-
creased from 11.1% in 1998 to 8.9% in
2001 and then increased slightly to 9.1%
in 2005 (Table 2). In men, the prevalence
decreasedfrom12.5%in1998to9.8%in
2001 and increased slightly to 10.2% in
2005, whereas in women, it decreased
consistently from 9.8% in 1998 to 8.2%
in 2001 and then to 7.9% in 2005. The
proportion of total cases that are known
was as low as 23.2% in 1998, rose to
41.2% in 2001, and increased signiﬁ-
cantly to 68.0% in 2005. When an A1C
level of 7.0% was used as a criterion,
adequate glucose control was achieved in
43.5% of those with known cases of dia-
betes in 2005, whereas only 22.9%
achieved adequate glucose control based
on an A1C level of 6.5%.
CONCLUSIONS — A number of ep-
idemiological studies have investigated
the prevalence of diabetes in Korea; how-
ever, no studies have assessed diabetes
managementamongKoreansatanational
level. In this regard, the present study
may be a signiﬁcant contribution. The
2005 KNHANES provides comprehen-
sive insights into the management status
of diabetes in Korea. In our analysis, the
age-standardized (aged 30 years) prev-
alencewas9.1%(10.2%inmenand7.9%
in women). From these results, Korea is
estimated to rank 14th among the 30 Or-
ganizationforEconomicCooperationand
Development countries in terms of diabe-
tes prevalence and 9th in terms of the
number of cases (13). However, the prev-
alence of diabetes among Koreans aged
30 years did not change signiﬁcantly
during this period (11.1% in 1998, 8.9%
in2001,and9.1%in2005).Basedonthis
trend, it may be concluded that the prev-
alence of diabetes in Korea has remained
relatively stable over the past 7 years.
Other developing countries in Asia
that have achieved rapid economic
growth have witnessed a huge increase in
the prevalence of diabetes. For example,
the prevalence of diabetes in China has
increased 119% since 1994 (14), and the
prevalence of diabetes in some urban ar-
eas of India has grown from 13.9% in
2001 to 18.6% in 2006 (15). The pattern
of recent changes in the prevalence of di-
abetes in Korea is slightly different from
thatinotherdevelopingcountriesinAsia,
and Korea is assumed to be intermediate
between developed countries and devel-
opingcountriesintermsoftheprevalence
of diabetes.
Our results showed that 68.0% of di-
abetic patients aged 30 years were
known cases of diabetes in 2005, a 1.7-
fold increase from 1998. This proportion
was higher than the 33.3% found in a
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from a 2004 survey in Thailand (16), and
the 54% from a 2000 survey in Seychelles
(17), but it was comparable to the 71%
shown in 2005 data from the U.S. (18).
Thus, the proportion of known cases of
diabetesinKoreaappearstobeincreasing
to a level matching that in developed
countries. The mean A1C level in our di-
abetic population was 7.4%, which was
slightly higher than the 7.2% reported for
the U.S. (NHANES III, 2003–2004) (19).
When adequate glucose control was de-
ﬁned as an A1C level of 7.0%, the ade-
quate control rate was 43.5%, which was
lower than the 56.8% shown in the U.S.
survey(19).Whenthemorestringentcri-
terion of the International Diabetes Fed-
eration was used (A1C 6.5%), the
adequate control rate was only 22.9%,
which was lower than the 31% indicated
in the European Cost of Diabetes in
Europe–Type II (CODE-2) study (20).
Furthermore,wefoundthattwo-thirdsof
thosewithdiabeteswerenotreceivinged-
ucation about diabetes and diabetes-
related complications (data not shown).
Therefore, although the proportion of
known cases of diabetes in Korea has
reachedthelevelseenindevelopedcoun-
tries, control of diabetes falls short of that
in developed countries.
Over the years, several methodologi-
cal changes, including the blood collec-
tion method and techniques for glucose
measurements, have been instituted in
the KNHANES. In 2005, blood was col-
lectedinNaF-containingtubes,whichare
known to inhibit ex vivo glycolysis (21).
In contrast with 2005, plain tubes were
used in 1998 and 2001. However, sam-
ples were drawn and immediately stored
on ice water in the KNHANES. Although
it is known that NaF-containing tubes in-
hibit glycolysis after sampling (21), it was
also reported that the decrease in glucose
concentration was similar in tubes both
with or without NaF if they are stored at
4°C (22). This observation indicates that
temperature is the most important stabi-
lizing factor (22). It is unlikely that col-
lecting samples in different tubes (plain
tubeandNaF-containingtube)mightsig-
niﬁcantly affect the prevalence estima-
tion. For glucose measurements, the
hexokinasemethodwasusedin2005and
the oxidase/peroxidase method was used
in 1998 and 2001, which may have over-
estimated the glucose level, although re-
ported differences between the two
methods are minimal (23,24). A method-
ological difference cannot explain the de-
crease in the prevalence of diabetes
between 1998 and 2001. There still re-
mains a possibility that nonfasting blood
samplesweremistakenlyregardedasfast-
ing samples in the 1998 survey, because
the 9.9% identiﬁed as nonfasting subjects
in 1998 was considerably lower than the
21.8% in 2001.
The KNHANES sampling procedure
was designed to produce a nationally rep-
Table 1—Prevalence of diabetes and IFG among Korean adults aged >30 years in 2005
Age
Total Men Women
n* % (95% CI) n* % (95% CI) n* % (95% CI)
Diabetes (years)†
30–39 119,899 1.4 (0.6–2.2) 69,946 1.6 (0.4–2.9) 49,953 1.2 (0.2–2.1)
40–49 610,673 7.4 (5.7–9.2) 397,209 9.5 (6.8–12.3) 213,464 5.3 (3.0–7.5)
50–59 716,872 14.0 (11.4–16.5) 488,435 19.0 (15.3–22.8) 228,437 8.9 (5.9–11.9)
60–69 654,298 18.1 (15.3–21.0) 295,820 17.7 (13.7–21.7) 358,478 18.5 (14.1–22.8)
70 479,974 17.9 (13.7–22.1) 163,954 16.8 (11.6–22.0) 316,020 18.5 (13.2–23.8)
30 2,581,716 9.1 (8.1–10.1) 1,415,364 10.2 (8.8–11.7) 1,166,352 7.9 (6.7–9.2)
Known diabetes (years)‡
30–39 30,184 0.4 (0.0–0.8) 21,858 0.5 (0.0–1.2) 8,326 0.2 (0.0–0.6)
40–49 290,071 3.5 (2.5–4.6) 221,601 5.3 (3.5–7.2) 68,470 1.7 (0.7–2.6)
50–59 518,996 10.1 (7.9–12.2) 334,193 13.0 (9.7–16.3) 184,803 7.2 (4.3–10.0)
60–69 528,782 14.6 (12.0–17.2) 232,311 13.9 (10.2–17.5) 296,471 15.3 (11.3–19.2)
70 391,398 14.6 (10.9–18.3) 131,749 13.5 (8.7–18.2) 259,649 15.2 (10.5–20.0)
30 1,759,431 6.2 (5.4–7.0) 941,712 6.8 (5.6–7.9) 817,719 5.6 (4.6–6.5)
Newly diagnosed diabetes
(years)§
30–39 85,553 1.0 (0.3–1.7) 48,088 1.1 (0.0–2.2) 37,465 0.9 (0.0–1.8)
40–49 320,602 3.9 (2.6–5.2) 175,608 4.2 (2.4–6.0) 144,994 3.6 (1.5–5.7)
50–59 200,447 3.9 (2.4–5.4) 156,813 6.1 (3.3–8.9) 43,634 1.7 (0.5–2.9)
60–69 127,188 3.5 (2.1–5.0) 65,181 3.9 (1.7–6.1) 62,007 3.2 (1.3–5.1)
70 88,576 3.3 (1.5–5.0) 32,205 3.3 (1.7–5.0) 56,371 3.3 (1.0–5.5)
30 822,366 2.9 (2.3–3.5) 477,895 3.5 (2.5–4.4) 344,471 2.4 (1.6–3.2)
IFG (years)
30–39 786,851 9.3 (7.6–10.9) 524,596 12.0 (9.2–14.8) 262,255 6.3 (4.4–8.2)
40–49 1,368,299 16.7 (14.2–19.1) 957,482 22.9 (18.9–26.8) 410,817 10.2 (7.9–12.5)
50–59 1,122,689 21.8 (18.5–25.2) 665,814 25.9 (20.9–30.8) 456,875 17.8 (13.3–22.3)
60–69 951,160 26.3 (22.8–29.9) 536,488 32.1 (26.3–37.9) 414,672 21.4 (17.1–25.7)
70 711,781 26.5 (21.8–31.3) 269,353 27.6 (19.1–36.1) 442,428 25.9 (20.7–31.1)
30 4,940,780 17.4 (16.1–18.7) 2,953,733 21.3 (19.2–23.5) 1,987,047 13.7 (12.2–15.1)
*The number of cases of prevalent diabetes and IFG is a 2005 population estimate. †Patients with known and newly diagnosed diabetes. ‡Patients with diabetes
previously diagnosed by a doctor. §Total number of diabetic patients excluding those with known diabetes. IFG is deﬁned as FPG between 100 and 125 mg/dl.
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weights were further adjusted for nonre-
sponseaccordingtodemographicfactors.
However, selective nonresponse still may
have had effects on prevalence estimates.
The response rate of health examination
in the 2005 KNHANES (72.4% for age
30 years) was slightly higher than that
of the U.S. NHANES 2005–2006 (69.4%
for age 30 years). To indirectly assess
the effects of nonresponse bias, we com-
pared several characteristics obtained
from the health interview survey between
participants and nonparticipants in the
health examination. Participants were
older (male only), more likely to have hy-
pertension (male only) and hypercholes-
terolemia (male and female), less
educated(maleonly),andlesslikelytobe
smokers (male and female) than nonpar-
ticipants. Monthly income, history of di-
abetes, and hospital admission for the last
year were not signiﬁcantly different be-
tween nonparticipants and participants.
After age adjustment, only smoking and
history of hypercholesterolemia were dif-
ferent between nonparticipants and par-
ticipants. Even though the difference was
not statistically signiﬁcant, more partici-
pants reported a history of diabetes than
did nonparticipants: 8.5 vs. 7.4% in men
(P  0.303) and 6.2 vs. 5.3% in women
(P  0.343). Thus, we could not rule out
thepossibilitythatnonresponsebiasleads
to overestimation of diabetes or IFG.
To summarize, the prevalence of dia-
betes in Korea has not changed signiﬁ-
cantly since 1998, but there has been a
substantial increase in the proportion of
known cases of diabetes. Nevertheless,
the proportion of patients receiving drug
treatmentandwithadequateglucosecon-
trol has yet to reach the level seen in de-
veloped countries. More intense efforts
for the prevention and treatment of dia-
betes will lead to further improvement in
the management of diabetes.
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